Effects of metronidazole on the fecal microbiome and metabolome in healthy dogs

  • Rachel Pilla
    Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences Texas A&M University College Station Texas USA
  • Frederic P. Gaschen
    Department of Veterinary Clinical Sciences School of Veterinary Medicine, Louisiana State University Baton Rouge Louisiana USA
  • James W. Barr
    Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences Texas A&M University College Station Texas USA
  • Erin Olson
    Department of Veterinary Clinical Sciences School of Veterinary Medicine, Louisiana State University Baton Rouge Louisiana USA
  • Julia Honneffer
    Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences Texas A&M University College Station Texas USA
  • Blake C. Guard
    Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences Texas A&M University College Station Texas USA
  • Amanda B. Blake
    Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences Texas A&M University College Station Texas USA
  • Dean Villanueva
    Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences Texas A&M University College Station Texas USA
  • Mohammad R. Khattab
    Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences Texas A&M University College Station Texas USA
  • Mustafa K. AlShawaqfeh
    School of Electrical Engineering and Information Technology German‐Jordanian University Amman Jordan
  • Jonathan A. Lidbury
    Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences Texas A&M University College Station Texas USA
  • Jörg M. Steiner
    Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences Texas A&M University College Station Texas USA
  • Jan S. Suchodolski
    Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences Texas A&M University College Station Texas USA

この論文をさがす

説明

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Metronidazole has a substantial impact on the gut microbiome. However, the recovery of the microbiome after discontinuation of administration, and the metabolic consequences of such alterations have not been investigated to date.</jats:p></jats:sec><jats:sec><jats:title>Objectives</jats:title><jats:p>To describe the impact of 14‐day metronidazole administration, alone or in combination with a hydrolyzed protein diet, on fecal microbiome, metabolome, bile acids (BAs), and lactate production, and on serum metabolome in healthy dogs.</jats:p></jats:sec><jats:sec><jats:title>Animals</jats:title><jats:p>Twenty‐four healthy pet dogs.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Prospective, nonrandomized controlled study. Dogs fed various commercial diets were divided in 3 groups: control group (no intervention, G1); group receiving hydrolyzed protein diet, followed by metronidazole administration (G2); and group receiving metronidazole only (G3). Microbiome composition was evaluated with sequencing of 16S rRNA genes and quantitative polymerase chain reaction (qPCR)‐based dysbiosis index. Untargeted metabolomics analysis of fecal and serum samples was performed, followed by targeted assays for fecal BAs and lactate.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>No changes were observed in G1, or G2 during diet change. Metronidazole significantly changed microbiome composition in G2 and G3, including decreases in richness (<jats:italic>P</jats:italic> < .001) and in key bacteria such as Fusobacteria (<jats:italic>q</jats:italic> < 0.001) that did not fully resolve 4 weeks after metronidazole discontinuation. Fecal dysbiosis index was significantly increased (<jats:italic>P</jats:italic> < .001). Those changes were accompanied by increased fecal total lactate (<jats:italic>P</jats:italic> < .001), and decreased secondary BAs deoxycholic acid and lithocholic acid (<jats:italic>P</jats:italic> < .001).</jats:p></jats:sec><jats:sec><jats:title>Conclusion and Clinical Importance</jats:title><jats:p>Our results indicate a minimum 4‐week effect of metronidazole on fecal microbiome and metabolome, supporting a cautious approach to prescription of metronidazole in dogs.</jats:p></jats:sec>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ